Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
C. Ayala-Orozco, D. Galvez-Aranda, A. Corona…·J. M. Tour
This paper introduces molecular jackhammers (MJH) that use vibronic-driven action (VDA) to kill cancer cells via necrosis using near-infrared light, showing high efficacy in vitro and in vivo.
P. M. Pifer, L. Yang, M. Kumar…·H. D. Skinner
This study identifies FAK as a driver of therapy resistance in HPV-negative HNSCC, showing its role is dependent on mutant TP53.
S. C. Callahan, M. Divenko, P. Barrodia…·K. Rai
This study shows KMT2D loss in HNSCC leads to enhancer reprogramming and immune microenvironment changes, promoting tumor growth through interferon signaling disruption.
S. C. Callahan, V. Kochat, Z. Liu…·K. Rai
The paper identifies high enhancer activity in HPV-negative atypical HNSCC as linked to BET inhibitor resistance and upregulated signaling pathways.
B. Uzunparmak, M. Gao, A. Lindemann…·C. R. Pickering
This study shows that loss of CASP8 function combined with SMAC mimetic treatment increases necroptosis in HNSCC, enhancing radiation sensitivity.
M. Kumar, D. Molkentine, J. Molkentine…·H. D. Skinner
The paper identifies CREBBP/EP300 as radiosensitization targets in mutant tumors by inhibiting histone acetyltransferase, which represses homologous recombination and increases radiation sensitivity.